FDA Approves Killer COVID Drug for Babies

While we have focused more on the COVID-19 vaccines that have created more deaths and injuries than all other FDA-approved vaccines for the previous 30 years, the other killer COVID drug currently being administered to the public is Remdesivir, with the brandname of “VEKLURY.” This drug, which was originally developed for ebola but never approved because it was so dangerous, has a history of scandals and many thousands of deaths since it was given an EUA (emergency use authorization) by the FDA, and then in October of 2020 it was fully approved by the FDA as a treatment for adults with COVID-19. To get the original EUA by the FDA, they had to attack existing drugs in the market that were already being proven as safe and effective against COVID-19 symptoms, such Ivermectin and hydroxychloroquine. A reasonable estimate of deaths caused by this killer drug worldwide would number in the millions. In September of 2021, Attorney Thomas Renz released to the public statistics on Remdesivir that a whistleblower had given to him from the CMS (Centers for Medicare & Medicaid Services) database, and the statistics were truly horrifying in terms of how many people were dying after taking this drug, which was over 25% of the patients. And now, the FDA has just approved this killer drug to be used with children, and babies as young as 28 days old.